Literature DB >> 3422639

Beta-oxidation of the carboxyl side chain of prostaglandin E2 in rat liver peroxisomes and mitochondria.

L Schepers1, M Casteels, J Vamecq, G Parmentier, P P Van Veldhoven, G P Mannaerts.   

Abstract

Rat liver and kidney homogenates, fortified with the appropriate cofactors, produced H2O2 when incubated with prostaglandin (PG) E2 or its CoA ester (PGE2-CoA), indicating that PGE2-CoA served as substrate for acyl-CoA oxidase, the first enzyme of peroxisomal beta-oxidation. PGE2-CoA oxidase was stimulated to the same extent as palmitoyl-CoA oxidase by treatment of rats with the peroxisome proliferator clofibrate. Subcellular fractionation confirmed that both oxidase activities were located in peroxisomes. When highly purified peroxisomes were incubated with [1-14C]PGE2, radioactive oxidation products were released, demonstrating that peroxisomes were capable of catalyzing the complete beta-oxidation sequence. However, PGE2 beta-oxidizing activity was expressed only when isolated microsomes were added to the purified peroxisomes, indicating that PGE2-CoA synthetase is located in the endoplasmic reticulum. Cofactor requirements for peroxisomal [1-14C]PGE2 and [1-14C]palmitate oxidation were identical, and oxidation was not inhibited by cyanide. [1-14C]PGE2 was also beta-oxidized by highly purified mitochondrial fractions, devoid of peroxisomes, when microsomes were added. Mitochondrial [1-14C]PGE2 and [1-14C]palmitate oxidation was CoA- and ATP-dependent and inhibited by cyanide. Palmitate oxidation was carnitine-dependent, but PGE2 oxidation was not. Acyl-CoA dehydrogenase activity, but not carnitine acyltransferase activity, was detected with PGE2-CoA as substrate. [1-14C]PGE2 oxidation in whole liver homogenates was only slightly inhibited by cyanide, indicating that peroxisomes oxidized the major portion of PGE2. The concentrations of PGE2 employed in these experiments exceeded the in vivo concentrations by several orders of magnitude. Therefore, we suggest that the urinary PG metabolite excretion be measured in patients with hereditary diseases in which peroxisomal or mitochondrial beta-oxidation is not functioning in order to clarify the role of each organelle in PG oxidation in vivo.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3422639

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

1.  Subcellular distribution and characteristics of ciprofibroyl-CoA synthetase in rat liver. Its possible identity with long-chain acyl-CoA synthetase.

Authors:  L Amigo; M C McElroy; M N Morales; M Bronfman
Journal:  Biochem J       Date:  1992-05-15       Impact factor: 3.857

Review 2.  Metabolite transport across the peroxisomal membrane.

Authors:  Wouter F Visser; Carlo W T van Roermund; Lodewijk Ijlst; Hans R Waterham; Ronald J A Wanders
Journal:  Biochem J       Date:  2007-01-15       Impact factor: 3.857

Review 3.  The inborn errors of peroxisomal beta-oxidation: a review.

Authors:  R J Wanders; C W van Roermund; R B Schutgens; P G Barth; H S Heymans; H van den Bosch; J M Tager
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

4.  The presence of acyl-CoA hydrolase in rat brown-adipose-tissue peroxisomes.

Authors:  S E Alexson; H Osmundsen; R K Berge
Journal:  Biochem J       Date:  1989-08-15       Impact factor: 3.857

5.  Hydroxyeicosatetraenoic acid metabolism in cultured human skin fibroblasts. Evidence for peroxisomal beta-oxidation.

Authors:  J A Gordon; P H Figard; A A Spector
Journal:  J Clin Invest       Date:  1990-04       Impact factor: 14.808

Review 6.  Prenatal and perinatal diagnosis of peroxisomal disorders.

Authors:  R B Schutgens; G Schrakamp; R J Wanders; H S Heymans; J M Tager; H van den Bosch
Journal:  J Inherit Metab Dis       Date:  1989       Impact factor: 4.982

7.  Studies on peroxisomes of colonic mucosa in Crohn's disease.

Authors:  I Aimone-Gastin; S Cable; J M Keller; M A Bigard; B Champigneulle; P Gaucher; J L Gueant; M Dauça
Journal:  Dig Dis Sci       Date:  1994-10       Impact factor: 3.199

8.  Metabolism of prostaglandin F2 alpha in Zellweger syndrome. Peroxisomal beta-oxidation is a major importance for in vivo degradation of prostaglandins in humans.

Authors:  U Diczfalusy; B F Kase; S E Alexson; I Björkhem
Journal:  J Clin Invest       Date:  1991-09       Impact factor: 14.808

9.  Impaired degradation of leukotrienes in patients with peroxisome deficiency disorders.

Authors:  E Mayatepek; W D Lehmann; J Fauler; D Tsikas; J C Frölich; R B Schutgens; R J Wanders; D Keppler
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

10.  Activation of a peroxisome-proliferating catabolite of cholic acid to its CoA ester.

Authors:  T Nishimaki-Mogami; A Takahashi; Y Hayashi
Journal:  Biochem J       Date:  1993-11-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.